Download FREE Sample
Table of Contents
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Market Forecasting
- Executive Summary
- Market Overview
-
- Market Dynamics
- Drivers
- Restraints
- Key Market Trends
- Industry Speaks
- Market Dynamics
- Key Revenue Pockets
- Global Nanomedicine Market - Size & Forecast (2022-2029), By Product Type
- Nanoparticles
- Metal & Metal Oxide Nanoparticles
- Liposomes
- Polymers & Polymer Drug Conjugates
- Hydrogel Nanoparticles
- Dendrimers
- Inorganic Nanoparticles
- Others
- Nanoshells
- Nanotubes
- Nanodevices
- Others
- Nanoparticles
- Global Nanomedicine Market - Size & Forecast (2022-2029), By Application Type
- Therapeutics
- In-vitro Diagnostics
- Drug Delivery
- In-vivo Imaging
- Implants
- Others
- Global Nanomedicine Market - Size & Forecast (2022-2029), By Indication Type
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopaedics
- Others
- Global Nanomedicine Market - Size & Forecast (2022-2029), By Region
- North America (U.S. & Canada)
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
- Asia Pacific (China, India, Japan, Rest of Asia Pacific)
- Rest of the World (Latin America, Middle East & Africa)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Competitive Positioning of Key Players (2023)
- Offerings Assessment, By Player
- Key Strategies Assessment, By Player (2022-2024)
- New Product & Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Key Companies Scanned (Indicative List)
- AbbVie Inc.
- AstraZeneca
- Bristol Myers Squibb
- Hoffmann-La Roche Ltd
- GE Healthcare
- Genentech, Inc.
- Merck & Co., Inc.
- Nanospectra Biosciences
- Nanobiotix
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
- Other Prominent Players
